microRNAs in Neurodegeneration: Current Findings and Potential Impacts

Significant advancements have been made in unraveling and understanding the non-coding elements of the human genome. New insights into the structure and function of noncoding RNAs have emerged. Their relevance in the context of both physiological cellular homeostasis and human diseases is getting appreciated. As a result, exploration of noncoding RNAs, in particular microRNAs (miRs), as therapeutic agents or targets of therapeutic strategies is under way. This review summarizes and discusses in depth the current literature on the role of miRs in neurodegenerative diseases.

Publication Date:
Jan 23 2018
Date Submitted:
Jun 28 2019
Journal of Alzheimer's Disease and Parkinsonism
External Resources:

 Record created 2019-06-28, last modified 2019-08-05

Rate this document:

Rate this document:
(Not yet reviewed)